ROYCE & ASSOCIATES LP - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q2 2022$764,000
-31.4%
349,0000.0%0.01%
-11.1%
Q1 2022$1,113,000
+5.8%
349,000
+39.0%
0.01%
+12.5%
Q4 2021$1,052,000
-33.9%
251,000
+28.1%
0.01%
-33.3%
Q3 2021$1,592,000
+54.0%
196,000
+43.1%
0.01%
+71.4%
Q2 2021$1,034,000
-13.0%
137,0000.0%0.01%
-12.5%
Q1 2021$1,189,000
+8.9%
137,0000.0%0.01%
-11.1%
Q4 2020$1,092,000
-0.1%
137,0000.0%0.01%
-25.0%
Q3 2020$1,093,000
-5.6%
137,000
+17.1%
0.01%
-7.7%
Q2 2020$1,158,000
+136.8%
117,000
+84.8%
0.01%
+85.7%
Q1 2020$489,00063,3120.01%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 964,141$7,829,0001.90%
Skylands Capital, LLC 1,837,541$14,921,0001.84%
CM Management, LLC 175,000$1,421,0001.06%
Soleus Capital Management, L.P. 800,000$6,496,0001.01%
Avenir Corp 1,395,385$11,331,0000.95%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 185,000$1,502,0000.55%
Winning Points Advisors, LLC 86,200$701,0000.51%
Granahan Investment Management 1,154,561$9,375,0000.18%
SECTORAL ASSET MANAGEMENT INC 244,660$1,987,0000.16%
Redmile Group, LLC 1,044,434$8,481,0000.15%
View complete list of CYTOSORBENTS CORP shareholders